Jounce Therapeutics, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Report date

3/31/2023

Quarter

2023 Q1

Filed

5/12/2023

Shares

226,160

Value ($000)

418

Weight

0.0%

2019 Q4 - 2023 Q1 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	5/12/2023	418	0.0%	226,160	3/31/2023
2022 Q4	2/13/2023	251	0.0%	226,160	12/31/2022
2022 Q3	11/14/2022	569	0.0%	242,759	9/30/2022
2022 Q2	8/15/2022	736	0.0%	242,875	6/30/2022
2022 Q1	5/13/2022	1,883	0.0%	277,288	3/31/2022
2021 Q4	2/11/2022	1,200	0.0%	143,678	12/31/2021
2021 Q3	11/16/2021	1,067	0.0%	143,585	9/30/2021
2021 Q2	8/16/2021	1,756	0.0%	258,092	6/30/2021
2021 Q1	5/17/2021	2,055	0.0%	200,023	3/31/2021
2020 Q4	2/16/2021	1,782	0.0%	254,523	12/31/2020
2020 Q3	11/13/2020	2,525	0.0%	309,384	9/30/2020
2020 Q2	8/20/2020	1,962	0.0%	284,319	6/30/2020
2020 Q1	5/15/2020	1,108	0.0%	233,085	3/31/2020
2019 Q4	2/7/2020	1,718	0.0%	196,738	12/31/2019